The program covers up to 3 IVF attempts and additional embryo transfers of cryopreserved embryos resulting from these attempts, designed for women up to age 38 who meet the specified requirements.

Full reimbursement is provided if pregnancy is not achieved. Pregnancy is confirmed when fetal heart function is detected at 7 weeks gestation.

The cost for this package is €9700, making it an ideal option for women and couples concerned about the financial implications of unsuccessful IVF attempts hindering their ability to continue further treatments. While we cannot guarantee successful outcomes, our high success rates enable us to offer this refund program. Participants will receive a refund if clinical pregnancy is not achieved, as determined by the absence of fetal heart function at 7 weeks gestational age.

DETAILS

The IVF and ICSI money-back guarantee program includes 3 cycles of ovarian stimulation for egg retrieval and embryo transfer, along with cycles involving resulting cryopreserved embryos. A minimum of 3 months must elapse between ovarian stimulation cycles. Each ovarian stimulation may result in cryopreserved embryos for future use. Under current regulations, any existing cryopreserved embryos must be used before undergoing a new ovarian stimulation. Consequently, participants will have cryopreserved embryos transferred between stimulations at no additional cost. If pregnancy is achieved and participants wish to keep the cryopreserved embryos, the annual cost is €300. Participants sign a contract with the clinic detailing all terms, legally binding both parties. Participants requiring PGD or PGS testing are ineligible for the program.

ELIGIBILITY REQUIREMENTS

The following criteria must be met:

REQUIRED TESTS

Male partner: Semen analysis (sperm count over 1 million spermatozoa per ml, with less than 100% abnormally shaped or immotile; analysis not older than 3 months) Semen culture and antibiogram Full blood exam Blood type and Rhesus factor Hemoglobin electrophoresis HBsAg (within the last semester) HCV (within the last semester) VDRL (within the last semester) HIV I-II (within the last semester) Karyotype CTRF

Female partner: FSH (3rd to 5th day of the menstrual cycle) with normal values in the proliferative phase LH (3rd to 5th day of the menstrual cycle) with normal values in the proliferative phase E2 <50 pg/ml PRL AMH/MIS over 2.8 ng/ml or 20 pmol/L TSH D4-Andr. DHEA-S (The above hormone tests should not be older than 3 months)

Full blood exam Blood type and Rhesus factor Hemoglobin electrophoresis Glycated Hemoglobin (HbA1c) Karyotype CTRF Hysterosalpingography or hysteroscopy (after gynecological surgery such as myomectomy, curettage, etc.) Breast ultrasound and/or Mammography HBsAg (within the last semester) HCV (within the last semester) VDRL (within the last semester) HIV I-II (within the last semester) Recent cardiology test

IMPORTANT NOTES

Participants must follow instructions provided by our gynecologists. The cost of medicines and pre-program tests is not included in the €9700 price. The cost of hormonal tests and ultrasounds, regardless of the number of program cycles until the first embryo transfer, is included in the program cost.

THE PROGRAM